Diagnostic and Interventional Cardiology

Patients who survive a heart attack together with sudden cardiac arrest are at increased risk of dying within six years following hospital discharge.

Survivors of Heart Attack Plus Cardiac Arrest at Increased Risk of Early Death

March 11, 2022 – Patients who survive a heart attack together with sudden cardiac arrest are at increased risk of dying ...

March 11, 2022

Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary artery disease? Under the leadership of Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions worked together to address this question as part of the DISCHARGE trial.

News | Computed Tomography (CT)

An Accurate and Low-Risk Diagnostic Test for Coronary Artery Disease

March 11, 2022 – Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary ...

March 11, 2022

A new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has identified unique features of MIS-C, a rare but potentially deadly complication of COVID in children, that suggest how the syndrome gets started.

News | Coronavirus (COVID-19)

Study Suggests How Post-COVID Syndrome, MIS-C, Gets Started in Children

March 11, 2022 – A new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has ...

March 11, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Poor heart health, especially among women of color, puts both mothers-to-be and their infants at risk, with heart disease causing more than one in four pregnancy-related deaths (26.5%) in the U.S., according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.

News | Womens Cardiovascular Health

$20 Million Committed for Research Focused on Health Equity in Maternal, Infant CVD Health

March 9, 2022 – Poor heart health, especially among women of color, puts both mothers-to-be and their infants at risk ...

March 09, 2022

Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design similarities shared with another device that was recently recalled for correction.

News | Atherectomy Devices

Class I Recall on TurboHawk Plus Directional Atherectomy System by Medtronic

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...

March 09, 2022

Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardiogram (ECG) devices increased the rate of diagnosis in patients 85 and older, but failed to show similar results in those 65 and older, a study by Massachusetts General Hospital (MGH) has found.

News | Atrial Fibrillation

Handheld Devices for A-fib Screening May be Most Effective in the Oldest Adults During Primary Care Visits

March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld ...

March 09, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

According to the American Heart Association, scientific research supports the view that losing an hour of much needed sleep may not be the only thing to dread about “springing forward” when clocks move up for daylight saving time later this month.

News | Heart Failure

Biological Clock Shock? “Springing Forward” May Have Drawbacks For Heart Health

March 9, 2022 – According to the American Heart Association, scientific research supports the view that losing an hour ...

March 09, 2022

The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yesterday afternoon on March 8.

Feature | Heart Failure

David Bennett, Pig Heart Transplant Patient, Dies

The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart ...

March 09, 2022

Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.

News | Point-of-Care Ultrasound (POCUS)

Fujifilm Sonosite Files Patent Infringement Lawsuit Against Butterfly Network

March 9, 2022 — Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it ...

March 09, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full-continuum platform which utilizes Emergency Medical Records (EMR) technology to streamline patient data transmission and analysis for various healthcare facilities.

News | ECG Monitoring Services

CardioTech Announces Partnership with VitalsXchange

March 8, 2022 – Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full ...

March 08, 2022

MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – "ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients.

News | Heart Failure

MemorialCare Heart and Vascular Institute Participating in Global Study of CSL112 in Patients with Acute Coronary Syndrome (AEGIS-II)

March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating ...

March 08, 2022

News | Heart Failure

Addressing the Difficulty of Diagnosing Heart Attacks After Heart Surgery

Mrach 8, 2022 – Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic ...

March 08, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.

News | Cardiovascular Business

AdvaMed Mourns the Passing of Wendy Siminski

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice ...

March 07, 2022

In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC’s Top 10 for the Month of February

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of ...

March 04, 2022

NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today announced dose administration for the first patient in its PREVAIL study, a global Phase 3 cardiovascular outcomes trial of the novel cholesteryl ester transfer protein (CETP) inhibitor obicetrapib

News | Heart Failure

NewAmsterdam Pharma Doses First Patient in its PREVAIL Study

March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of ...

March 04, 2022